Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
about
Inflammation in arterial diseasesAltered cytokine levels in pediatric ITP.The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcomeTear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseChemokines and chemokine receptors in arthritis.CNS immune responses following experimental strokeDecreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation.Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions.Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityInduction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.Fractalkine in rheumatoid arthritis: a review to date.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans.Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways.Role of CX3CL1 in Diseases.Fractalkine/CX3CL1 in rheumatoid arthritis.CCL5, CXCL16, and CX3CL1 are associated with Henoch-Schonlein purpura.Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis.Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus.The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis.Expression of CX3CL1 and its receptor, CX3CR1, in the development of periapical lesions.Involvement of CX3CL1 in the Migration of Osteoclast Precursors Across Osteoblast Layer Stimulated by Interleukin-1ß.ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion
P2860
Q26853576-FE1403BB-3BCA-4F76-B05D-A3B8DA747022Q33421423-F0403500-4818-4CF6-AF75-712D8E2E5102Q33615950-14E4AE0B-1A37-4B99-BA4B-83514274B3B1Q33869200-8905F44B-DCC5-4A7F-9C70-90D4EFD4B218Q34051768-E0AB2178-43E2-4698-96D5-A417279E2DF3Q34232353-194D520D-7DBB-42D3-8704-9BFB7057D3D2Q35616110-1BA88AD2-8C85-4BE5-814B-1FB5E9F4D9B5Q35624562-AA8FA97A-51F2-4CAB-A588-25DACCEC3134Q35927383-CBBCF1AD-319C-4DFE-AA8F-5EACEEC00CE1Q36245680-4323744E-8D42-4EE7-8FD7-701C4D997EE7Q37158146-8A6EEBC1-7DB5-4810-B28A-92D768C928C3Q37170088-EE44CFC7-A863-445F-91F1-3D69800E91FEQ37300823-0AC2DE0A-FB43-4DAA-BC9E-4A7759499458Q37411925-14E95C27-B294-4FD9-B8D3-84690CEBD156Q38294927-EA1E1EF4-5A34-454C-9DCB-712304FA1D80Q38813214-90EFDC68-33F3-47E4-8C02-008907E03D5CQ38916484-9279306A-A0E2-495F-B845-C1A7F202BA98Q39531142-7382977E-3A3D-41AE-8052-257E4DF504D4Q41534964-67C9E8D3-7D81-4829-9D72-2EC6E2ABD5CAQ41623712-8C2FA97C-1114-474E-9662-7D53F77D50AAQ50248970-6A7B45C8-5A45-4481-9F23-3B55B359F761Q50856307-36C342D1-4C2A-45AA-8D86-99030840474BQ51540881-E8FBC297-A992-4890-871D-38F79F84090CQ58803189-97C0810B-FEAF-42BD-8D3F-9F60F34100A8
P2860
Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Increased serum levels of solu ...... vity in rheumatoid vasculitis.
@en
Increased serum levels of soluble fractalkine
@nl
type
label
Increased serum levels of solu ...... vity in rheumatoid vasculitis.
@en
Increased serum levels of soluble fractalkine
@nl
prefLabel
Increased serum levels of solu ...... vity in rheumatoid vasculitis.
@en
Increased serum levels of soluble fractalkine
@nl
P2093
P2860
P356
P1476
Increased serum levels of solu ...... ivity in rheumatoid vasculitis
@en
P2093
Hiroko T Takeuchi
Hirotsugu Ide
Masao Negishi
Mitsuru Adachi
Mizuho Matsunawa
Takeo Isozaki
Tsuyoshi Kasama
Tsuyoshi Odai
P2860
P304
P356
10.1002/ART.22208
P577
2006-11-01T00:00:00Z